SCHEMBL4428692

SCHEMBL4428692

O=C(Nc1ccc(Oc2ccccc2)cc1)C1=C(O)[C@H]2CCC[C@H]2NC1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNLIP P16233 4/20 0.48
PGR P06401 1/20 0.46
FNTA P49354 1/20 0.45
FNTB P49356 1/20 0.45
EPHX1 P07099 1/20 0.45
MAPT P10636 5/20 0.44
ALDH1A1 P00352 2/20 0.44
TP53 P04637 2/20 0.43
POLB P06746 2/20 0.43
RAB9A P51151 2/20 0.43
HPGD P15428 2/20 0.43
NPC1 O15118 1/20 0.43
SMN1; SMN2 Q16637 4/20 0.41
LMNA P02545 3/20 0.41
MEN1 O00255 1/20 0.41
USP2 O75604 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 1/20 0.41
HSD17B10 Q99714 1/20 0.41
ALOX12 P18054 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4428693 1.00 PNLIP (0.48) PNLIPPGRFNTAFNTBEPHX1
SCHEMBL4428695 1.00 PNLIP (0.48) PNLIPPGRFNTAFNTBEPHX1
SCHEMBL4413782 0.88 DHODH (0.42) MAPTRAB9AHPGDNPC1SMN1; SMN2
SCHEMBL4413780 0.88 DHODH (0.42) MAPTRAB9AHPGDNPC1SMN1; SMN2
SCHEMBL4413784 0.88 DHODH (0.42) MAPTRAB9AHPGDNPC1SMN1; SMN2
SCHEMBL4420661 0.86 PGR (0.43) PNLIPPGRFNTAFNTBEPHX1
SCHEMBL4417920 0.84 EPHX2 (0.46) EPHX1ALDH1A1POLBNPC1SMN1; SMN2
SCHEMBL4417924 0.84 EPHX2 (0.46) EPHX1ALDH1A1POLBNPC1SMN1; SMN2
SCHEMBL4417929 0.84 EPHX2 (0.46) EPHX1ALDH1A1POLBNPC1SMN1; SMN2
SCHEMBL13598145 0.84 SMN1; SMN2 (0.43) PNLIPPGRMAPTALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090325948-A1 INHIBITORS OF UNDECAPRENYL PYROPHOSPHATE SYNTHASE HURLEY TIMOTHY BRIAN 2009-12-31 US disclosed
US-20090325948-A1 INHIBITORS OF UNDECAPRENYL PYROPHOSPHATE SYNTHASE HURLEY TIMOTHY BRIAN 2009-12-31 US disclosed
US-20090325948-A1 INHIBITORS OF UNDECAPRENYL PYROPHOSPHATE SYNTHASE HURLEY TIMOTHY BRIAN 2009-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090325948-A1 INHIBITORS OF UNDECAPRENYL PYROPHOSPHATE SYNTHASE FDPS, UMPS, GGPS1 PNLIP 433/4885PGR 3020/4885FNTA 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.